Comparison of cluster-based and source-attribution methods for estimating transmission risk using large HIV sequence databases.. Epidemics.. 2017.
The association between detected drug resistance mutations and CD4+ T-cell decline in HIV-positive individuals maintained on a failing treatment regimen.. Antivir Ther.. 2017.
Nondisclosed MSM link together in HIV transmission networks. 24th International HIV Dynamics and Evolution.. 2017.
Identifying the sources of recent HIV infection in a UK cohort. 24th International HIV Dynamics and Evolution.. 2017.
Phylodynamic analysis to guide allocation of Pre-Exposure Prophylaxis in the United Kingdom. 24th International HIV Dynamics and Evolution.. 2017.
Source of HIV-1 drug-resistant minority variants in people who are recently infected. 24th International HIV Dynamics and Evolution.. 2017.
An association between K65R and HIV-1 subtype C viruses in patients treated with multiple NRTIs. J Antimicrob Chemother.. 2017.
Clinical Status of Adolescents with Perinatal HIV at Transfer to Adult Care in the UK/Ireland. Clin Infect Dis. Epub ahead of print. 2017.
HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK. J Antimicrob Chemother. 71(12). 2016.
Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen. J Antimicrob Chemother. 71:1352-60.. 2016.
Virological failure and development of new resistance mutations according to CD4 count at combination antiretroviral therapy initiation. HIV Med. 17:368-72.. 2016.
Transmission of Non-B HIV Subtypes in the United Kingdom Is Increasingly Driven by Large Non-Heterosexual Transmission Clusters. J Infect Dis. 213:1410-8.. 2016.
No evidence that HIV-1 subtype C infection compromises the efficacy of Tenofovir-containing: Cohort study in the United Kingdom. J Infect Dis.. 2016.